THE 'NEW' DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE

Autor:	S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
Jazyk:	English<br />Russian
Rok vydání:	2015
Předmět:	хроническая сердечная недостаточность рандомизированное клиническое исследование ивабрадин омега-3 полиненасыщенные жирные кислоты Therapeutics. Pharmacology RM1-950 Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Рациональная фармакотерапия в кардиологии, Vol 8, Iss 2, Pp 211-219 (2015)
Druh dokumentu:	article
ISSN:	1819-6446 2225-3653
DOI:	10.1234/1819-6446-2012-2-211-219
Popis:	A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base of GISSI-HF and SHIFT trails results. It is essential to compaire an effect of these drugs on the morbidity and mortality in combined therapy of patients with CHF , because each additional drug may change in compliance to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy) effects of ivabradine and omega-3 polyunsaturated fatty acids are discussed.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/938ed44d108446cfbf1f15d5ddd7ce70 Zobrazit plný text záznamu View record in DOAJ